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ABSTRACT
Graft-versus-host disease (GVHD) is a potentially fatal complication after allogeneic bone marrow transplan-
tation. However, few data exist thus far on the molecular signals governing leukocyte trafficking during the
disease. We therefore investigated the sequential pattern of distinct adhesion, costimulatory, and apoptosis-
related molecules in GVHD organs (ileum, colon, skin, and liver) after transplantation across minor histo-
compatibility barriers (B10.D2 ¡ BALB/c, both H-2d). To distinguish changes induced by the conditioning
regimen from effects achieved by allogeneic cell transfer, syngeneic transplant recipients (BALB/c¡ BALB/c)
and irradiated nontransplanted mice were added as controls. Irradiation upregulated the expression of vascular
cell adhesion molecule (VCAM)–1, intercellular adhesion molecule (ICAM)–l, and B7-2 in ileum, as well as
VCAM-1 and B7-2 in colon, on day 3 in all animals. Whereas in syngeneic mice these effects were reversed
from day 9 on, allogeneic recipients showed further upregulation of VCAM-1, ICAM-1, B7-1, and B7-2 in
these organs on day 22, when GVHD became clinically evident. Infiltration of CD4 and CD8 donor T cells
was noted on day 9 in skin and liver and on day 22 in ileum and colon. Surprisingly, the expression of several
other adhesion molecules, such as ICAM-2, platelet-endothelial cell adhesion molecule 1, E-selectin, and
mucosal addressin cell adhesion molecule 1, did not change. Proapoptotic and antiapoptotic markers were
balanced in GVHD organs with the exception of spleen, in which a preferential expression of the proapoptotic
Bax could be noted. Our results indicate that irradiation-induced upregulation of VCAM-1, ICAM-1, and B7-2
provides early costimulatory signals to incoming donor T cells in the intestine, followed by a cascade of
proinflammatory signals in other organs once the alloresponse is established.
© 2005 American Society for Blood and Marrow Transplantation
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mNTRODUCTION
Graft-versus-host disease (GVHD) is a pathologic
ondition in which allogeneic T cells react against
ecipient minor histocompatibility antigens (miHAgs)
f the immunocompromised host [1]. Most fre-
uently, this occurs after allogeneic bone marrow
ransplantation (BMT), when activated donor T cells
re transplanted into a patient whose hematologic and a
B&MTmmunologic compartments have recently been ab-
ated by high-dose chemoradiotherapy. One of the
ost striking observations regarding GVHD is that it
oes not affect all host organs in a similar fashion but
reserves a characteristic pattern of organ involve-
ent regardless of the type of transplant used. The
ost frequently involved organs are the skin, liver,
nd intestine [2], as well as the hematopoietic system
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3nd thymus. The reasons for this characteristic organ
ropism are not fully understood [3].
The circulation of leukocyte subsets from the
lood into the different compartments of the body,
here they can exert their speciﬁc functions, requires
complex interaction of selectins, integrins, and other
embers of the immunoglobulin superfamily with
heir respective ligands [4]. This system of leukocyte
rafﬁcking is highly ﬂexible and allows redirection of
eukocytes to new sites of inﬂammation within min-
tes. The process of leukocyte homing to their desig-
ated areas involves several consecutive steps [5]: (1)
olling of leukocytes on endothelial cell surfaces me-
iated by different types of selectins, (2) activation and
rm adhesion of target cells on endothelial cells me-
iated by integrins, and, ﬁnally, (3) transendothelial
igration of the cells into the tissue, which requires
he platelet-endothelial cell adhesion molecule
PECAM) 1 [6] and a gradient of other chemotactic
ubstances. Several of these cellular adhesion mole-
ules (CAMs) have been shown to be expressed in a
issue-speciﬁc way. The mucosal addressin cell adhe-
ion molecule (MAdCAM)–1 seems to be important
or the homing of 47
 activated T cells to Peyer
atches [7], whereas the interaction of intestinal intra-
pithelial lymphocytes with epithelial cells is mediated
y E-cadherin and E7 integrin [8]. The lectin en-
othelial leukocyte adhesion molecule E-selectin di-
ects cutaneous lymphocyte antigen–positive T cells
nto the skin [9]. Therefore, it has been postulated that
he characteristic organ tropism of GVHD may
e—at least in part—explained by a differential ex-
ression pattern of adhesion molecules in GVHD
arget organs [5].
To be able to exert effector functions, T cells not
nly have to enter the tissue where their antigen of
nterest is expressed, but also need further stimulation
n context with antigen. Therefore, in addition to
riggering through the T-cell receptor, T cells require
second, costimulatory signal, which is usually pro-
ided by the same antigen-presenting cell that pre-
ents the antigen. Although the importance of adhe-
ion and costimulatory molecules for the induction of
VHD is well established, blocking studies against
everal candidate molecules have been only partially
uccessful [10-13]. This failure could be explained by
he lack of sequential data on the expression of these
olecules during the different phases of murine
VHD.
In this study, we therefore decided to provide a
omprehensive time- and organ-resolved analysis of
istinct adhesion molecules (vascular cell adhesion
olecule [VCAM]–1, intercellular adhesion molecule
ICAM]–1 and ICAM-2, E-selectin, PECAM-1, and
AdCAM-1) and their ligands (lymphocyte function-
ssociated antigen [LFA]–1, 4 integrin, and 7 inte-
rin), T-cell costimulatory signals (B7-1 and B7-2), w
72nd apoptotic markers (Bax, Bcl-2, Fas, and FAS li-
and [Fas-L]) in a murine model of GVHD across
iHAg barriers (B10.D2/nSnJ ¡ BALB/c, both
-2d) [10,14]. The GVHD target organs skin, liver,
leum, and colon were examined on day 3 (aplasia), day
(hematopoietic reconstitution), day 22 (early phase
f GVHD), and day 28 (advanced phase of GVHD) by
mmunohistochemistry or reverse transcription-poly-
erase chain reaction (RT-PCR). The results of the
llogeneic transplanted group were compared with the
esults from untreated and irradiated control mice
BALB/c), as well as with results from a syngeneic
ransplanted group (BALB/c ¡ BALB/c). These
ovel results provide insight into the sequential pat-
ern of early effects induced by the conditioning reg-
men, as well as subsequent effects induced by the
xpanding allogeneic cells inside the host.
ATERIALS AND METHODS
ice
Female B10.D2/nSnJ (H2d, Mtv-7, Mtv-1,
tv-6, Mtv-13) donor and female BALB/c recipi-
nt (H-2d, Mtv-7, Mtv-1, Mtv-6, Mtv-13) mice
iffer in miHAgs [15], as well as endogenous superan-
igens [16]. Mice were purchased from The Jackson
aboratory (Bar Harbor, ME) and maintained in
igh-efﬁciency particulate air–ﬁltered cabins (Sean-
ainer Type C110; Scanbur, Karlslunde, Denmark)
nder standard pathogen-free conditions at 22°C,
ith controlled air ﬂow and a 12-hour day/night
hythm.
one Marrow Transplantation
Allogeneic BMT. BALB/c recipients (13-16 weeks
ld) were preconditioned for BMT by fractionated
otal body irradiation (10 Gy) from a linear accelerator
Linac; Electra, Hamburg, Germany). In initial titra-
ion studies, the lethal irradiation dose from the linear
ccelerator had been determined as 2 fractions of 5 Gy
ach with an interval of 8 hours. Bone marrow was
btained by ﬂushing the femurs and tibiae from
ealthy B10.D2/nSnJ donors (13-15 weeks old).
plenocytes (as a source of T cells) were obtained by
omogenizing spleens of B10.D2/nSnJ donors. Four
o 6 hours after irradiation, recipient BALB/c hosts
ere reconstituted with a single intravenous injection
f 10 106 B10.D2/nSnJ bone marrow cells and 100
06 spleen cells, as previously described [10].
Syngeneic BMT. As a control, bone marrow and
pleen cells were obtained similarly from healthy
ALB/c donors and given to irradiated BALB/c re-
ipients. For an irradiation control, BALB/c mice
ere lethally irradiated (10 Gy) without receiving
one marrow or spleen cells. Organs of these mice
ere analyzed on day 3 after irradiation.
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Adhesion and Costimulatory Molecules in Murine GVHD
BBecause of the large number of animals (n  60),
ransplantations were performed on 2 separate days.
he experimental protocol was approved by the Ani-
al Care Committee of the University of Tuebingen.
low Cytometry
Spleens were homogenized, and cells were ﬁltered
hrough a 100-m cell strainer (BD, Heidelberg,
ermany) and washed. After density centrifugation
20 minutes, 1500g, 22°C) on a murine Ficoll gradient
Cedarline, Hornby, Ontario, Canada), mononuclear
ells were harvested, washed, and resuspended at a
oncentration of 2  106/mL. Cells were stained with
D3-phycoerythrin (PE), CD4 (L3T4)–ﬂuorescein
sothiocyanate (FITC), CD8 (Ly2)–FITC, V3 T-cell
eceptor–PE, DX5-PE (natural killer [NK] cells),
D45R/B220-FITC (B cells), and Ly9.1-FITC (di-
ected against antigens expressed on lymphocytes of
ALB/c, but not of B10.D2/nSnJ, mice; all obtained
rom Pharmingen, Hamburg, Germany) by using
tandard procedures. A total of 10 000 cells per sample
ere acquired and analyzed on a FACSCalibur by
sing CellQuest software (BD).
reparation of Frozen Tissue for Sectioning
Tissue expression of adhesion molecules was ana-
yzed during the phases of aplasia (day 3) and engraft-
ent (day 9) and during different stages of GVHD
days 21 and 28). Mice were killed with CO2, and
arget organs of GVHD (skin, liver, ileum, and colon)
ere prepared, embedded in frozen tissue matrix
OCT embedding compound; Leica, Nussloch,
ermany), shock-frozen in liquid nitrogen, and stored
t 80°C. Frozen sections were prepared with a
ryocut (CM 3000; Leica): 6 to 10 sections were
laced on electrostatic pretreated glass slides, air-
ried, ﬁxated for 8 minutes in acetone, and stored at
20°C.
ntibodies
Primary antibodies were obtained from PharMin-
en: rat anti-mouse immunoglobulin (Ig)G—CD4
H129.19), CD8 (53-6.7), CD11a (M17/4), CD29
9EG7), CD31 (Mec13.3), CD49d (9C10), CD62E
10E9.6), CD80 (1G10), CD86 (GL1), CD102 (3C4),
D106 (429 MVCAM.A), MAdCAM-1 (MECA-
67), and 7 integrin (M293); hamster anti-mouse
mmunoglobulin—CD28 and CD54 (3E2). Biotinyl-
ted secondary antibodies were rabbit anti-rat IgG
Dako, Hamburg, Germany), goat anti-Armenian
amster IgG, and goat anti-Syrian hamster IgG
PharMingen).
mmunohistochemistry
Frozen sections were stained with the avidin-bi-
tin-peroxidase complex immunoperoxidase tech- t
B&MTique [17]. Sections were pretreated with 3% goat or
abbit serum in phosphate-buffered saline (PBS) to
educe nonspeciﬁc background. A washing step fol-
owed, after which the primary antibody (rat or ham-
ter anti-mouse IgG, 1:100) was applied and incubated
or 45 minutes at room temperature in a humidiﬁed
hamber. The slides were washed again in PBS, and a
iotin-labeled secondary antibody was applied for 1
our (goat or rabbit anti-rat or anti-hamster antibody,
:50, with 1% sterile bovine serum albumin). Slides
ere washed, and sections were covered with
:200 streptavidin-peroxidase for 1 hour. After an-
ther washing step, the substrate solution (4 mg of
-amino-9-ethylcarbazole in 0.5 mL of N,N-dimeth-
lformamide and 9.5 mL of 0.1 mol/L sodium acetate
uffer ﬁltered through a 0.2-m sterile ﬁlter) was
laced on the sections and incubated for 8 to 15
inutes. The reaction was stopped with PBS, and a
ematoxylin counterstain (Mayer’s) was performed.
tained sections were covered in glycerin/gelatin. Pri-
ary antibodies were replaced by PBS in negative
ontrols. For immunoﬂuorescence microscopy, a
ITC-labeled streptavidin-peroxidase dilution was
sed. After 1 hour of incubation, slides were washed,
overed with Citiﬂuor (Plano, Wetzlar, Germany),
nd stored at 4°C in the dark until analysis.
Samples were visualized on an Olympus BX6O
icroscope (Olympus, Hamburg, Germany) and dig-
tized with the Camera CF-15MC (MCU-II; Kappa
mbH, Germany). Each molecule was compared se-
uentially within 1 organ of allogeneic and syngeneic
ransplants, irradiation controls, and nontransplanted
ice. The number of animals studied at each time
oint varied from 3 to 6 (Figures 1-4). From each
rgan, multiple sections of 2 slides were analyzed
efore the degree of expression was determined. The
xperiment was performed 2 times with 30 trans-
lanted animals in each experiment. Because no vari-
tion was observed between the 2 experiments, data
rom the 2 experiments were pooled. Four hundred of
he 7000 slides were re-evaluated by a second inves-
igator (P.G.S.), and consistency with the primarily
btained results was conﬁrmed.
To determine the relative degree of expression of
he respective molecules, a semiquantitative scoring
ystem was developed, according to previously pub-
ished studies [18,19]. Low expression (grade 1) was
eﬁned as the occasional detection of isolated positive
ells (2-5 per section); formation of cellular aggregates
as interpreted as intermediate expression (grade 2),
nd conﬂuence of aggregates or, in the intestine, ag-
regates in each villus was interpreted as strong ex-
ression (grade 3). Representative examples of all de-
rees of expression can be seen in Figure 3. Different
ypes of cells (lymphocytes, macrophages, endothelial
ells, epithelial cells, and so on) were identiﬁed by
heir distinct location and morphology.
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3everse Transcription-Polymerase Chain Reaction
In allogeneic transplanted animals, RNA was ex-
racted from skin, liver, ileum, and colon after homog-
nizing samples in GuaSCN buffer by using a homog-
nizing device (Heidolph, Schwabach, Germany) and
oading the lysate onto a CsCl gradient. Complemen-
ary DNA was synthesized by reverse transcription by
sing standard procedures. Complementary DNA
as ampliﬁed in a 50-L standard PCR reaction.
efore analysis, PCR conditions were optimized for
ach primer pair. PCR primers were as follows: Bax
ense, 5=-TACAGGGTTTCATCCAGGATCG-
=; Bax antisense, 5=-GTGTCCACGTCAGCAAT-
ATCC-3= (fragment size, 175 base pairs [bp]; an-
ealing temperature, 60°C; optimal PCR
erformance with 28 cycles); Bcl-2 sense, 5=-ATG-
TACATACCCAGTCAGAGG-3=; Bcl-2 anti-
ense, 5=-ACAGAGTGAGTATTGGAGGAGG-3=
248 bp; 60°C; 28 cycles); Fas sense, 5=-CTCAAG-
TACTAATAGCATCTCCGAGAG-3=; Fas anti-
ense, 5=-TTGCACTTGCACTTGGTAT-TCTGG-3=
316 bp; 60°C; 35 cycles); Fas-L sense, 5=-GAAGGAACT-
GCAGAACTCCGTG-3=; and Fas-L antisense, 5=-
TTGATCAGAGAGAGTTGAGATATGTTG-
CA-3= (481 bp; 60°C; 35 cycles). PCR conditions
ere 94°C at 5 min for denaturation, cycling (dena-
uration at 94°C for 30 seconds, primer-speciﬁc an-
ealing temperature for 30 seconds, and elongation at
igure 1. Expression of VCAM-1 in GVHD target organs. Express
ell as in syngeneic ( ) and allogeneic () transplanted mice. Expre
ymbol represents 1 animal, analyzed at the respective time poi
xperiments. Expression of VCAM-1 is shown in ileum (A), colon
xpression in ileum and colon of all treated animals. Whereas expre
t remained increased in the allogeneic group until day 22 (ileum, P
n day 22). In skin and liver, VCAM-1 increased from day 9 on in2°C for 30 seconds; the number of cycles was opti- g
74ized for each primer), and a ﬁnal elongation step at
2°C for 7 minutes. After ampliﬁcation, PCR prod-
cts were denatured and visualized on an 8% poly-
crylamide gel.
Each PCR included ampliﬁcation of -actin from
he same organ as an internal standard, and both PCR
roducts were loaded onto the same lane. In a semi-
uantitative analysis, the optical density of the mole-
ule of interest was divided by the optical density of
he internal -actin standard by using AIDA software
Raytest, Straubenhardt, Germany).
tatistics
For comparison of different grades of tissue ex-
ression (ordinal scale) among naive BALB/c mice,
rradiation controls, and syngeneic and allogeneic
ransplants (nominal scale), the 2 test was used at
elected time points to test for signiﬁcant differences
etween groups. If both variables had only 2 levels, the
isher exact test was applied. P 	 .05 was considered
tatistically signiﬁcant.
ESULTS
ransplantation
After lethal irradiation and subsequent BMT,
here was a profound loss of weight in the syngeneic
VCAM-1 was analyzed in untreated and irradiated controls (), as
as assessed as absent (0), weak (1), moderate (2), or strong (3). Each
rs represent median values. Data were pooled from 2 separate
in (C), and liver (D). Irradiation induced an increase in VCAM-1
eturned to baseline levels in syngeneic transplanted mice on day 9,
37; colon, P 	 .0476 in untreated controls versus allogeneic mice
ogeneic, but not in the syngeneic transplanted group.ion of
ssion w
nts; ba
(B), sk
ssion r
	 .03roup, as well as in the allogeneic group. Weight
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Adhesion and Costimulatory Molecules in Murine GVHD
Beturned to baseline after approximately 2 weeks.
owever, in contrast to syngeneic transplanted mice,
hich maintained their body weights throughout the
ntire observation period thereafter, allogeneic trans-
lanted mice exhibited a second loss of weight after
ay 21 (Figure 5A), which coincided precisely with the
nset of clinical symptoms compatible with GVHD.
n day 22, 10 of 16 mice in the allogeneic group
resented with erythema of the skin and loss of fur.
igure 2. Expression of 4 and 7 integrin in GVHD target organs.
llogeneic bone marrow transplantation resulted in accumulation
f activated donor T cells in GVHD target organs. This tissue
nﬁltration could be detected from day 9 on in skin and liver and
ater from day 22 on in the ileum and colon. A, Representative
xamples of immunohistochemical 4 integrin staining in skin of
ntreated controls (left) and allogeneic transplanted mice (right) on
ay 9 are shown. This increase of expression was statistically sig-
iﬁcant (P  .0146). B, Immunoﬂuorescence staining conﬁrming
he signiﬁcant increase (P  .0005) of 4 integrin–positive cells in
leum of allogeneic transplanted animals from day 3 (left) to day 22
right). Whereas in liver and ileum, the expression of 4 and 7
ntegrin increased in parallel and lymphocytes positive for both
arkers were colocalized, in skin these 2 molecules were expressed
n distinct cell populations. C, Different location of cutaneous 4
ntegrin–positive and 7 integrin–positive cells. 4 Integrin–positive
ells were localized in the dermis (left), whereas 7 integrin–positive
ells could predominantly be found in the epidermis of syngeneic
middle) and allogeneic (right) transplanted animals. This indicates
hat 4 and 7 integrin are expressed on different cell populations in
kin after transplantation.n day 24, all mice in the allogeneic group (16/16) n
B&MThowed these symptoms of murine GVHD, with a
urther aggravation toward the end of the observation
eriod.
Flow cytometric assessment of splenic lymphocyte
ubsets on days 9 and 22 revealed immune reconsti-
ution of T, B, and NK cells in both groups, which
ere almost exclusively Ly9.1 in the autologous
roup and Ly9.1 in recipients of allogeneic grafts,
ndicating full donor engraftment in the latter group
data not shown). It is interesting to note that
here was a marked expansion of V3CD4 and
3CD8 T cells on day 9 and day 22 in the allo-
eneic group, but not in the syngeneic group (Figure 5B).
xpression of VCAM-1, 4 Integrin, and
7 Integrin
VCAM-1 was weakly expressed in lymphoid aggre-
ates of Peyer patches, the lamina propria, and the sub-
ucosa of normal murine ileum and colon. On day 3,
CAM-1 was upregulated from a weak expression in
ntreated controls to an intermediate expression in il-
um and colon in all treated groups (syngeneic, alloge-
eic, and irradiation controls). In the ileum and colon of
yngeneic controls, VCAM-1 was downregulated back
o pretransplantation levels on day 9, whereas it re-
ained increased in allogeneic transplanted mice until
ay 22 (ileum, P  .0337; colon, P  .0476; Figure 1A
nd B). In contrast to the intestinal organs, expression of
CAM-1 in the skin and liver of the syngeneic group
emained weak, but an upregulation was observed on day
in the allogeneic group. In skin, VCAM-1 was consti-
utively expressed on dermal and subcutaneous cells. In
he course of GVHD, upregulation of VCAM-1 was
een in the dermis, and single positive cells also appeared
n the epidermis (Figure 1C). In the liver, VCAM-1 was
onstitutively expressed in close proximity to liver veins,
ut with upregulation from weak to moderate expression
n day 9 and 22 after allogeneic BMT, VCAM-1 cells
ould also be found in the liver parenchyma (Figure 1D).
The 4 integrin, which is expressed on activated
ymphocytes, is known to serve as a ligand for
CAM-1. It was constitutively expressed on lympho-
ytes in all organs at weak to moderate levels. Only in
kin, 4 integrin was also expressed on cells with a
endritic morphology. In all treated animals, expres-
ion remained constant or decreased because of irra-
iation-induced aplasia on day 3 and returned to pre-
ransplantation levels in syngeneic controls on day 9.
fterward, no signiﬁcant changes in expression of 4
ntegrin could be observed in syngeneic controls.
owever, in the allogeneic group there was a signiﬁ-
ant increase of 4 integrin–positive cells between day
and day 9 in skin (P  .0076) and liver (P  .0112)
nd between day 3 and day 22 in ileum (P  .0005)
nd colon (P  .0421; Figure 2A). In liver, clusters of
4 integrin–positive lymphocytes appeared after day 9,
ot only in the surrounding of liver veins, but also in
375
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3he liver parenchyma. The increased expression of 4
ntegrin in intestinal organs was conﬁrmed by immu-
oﬂuorescence staining (Figure 2B). Expression re-
igure 3. Expression of ICAM-1 and its ligand LFA-1 in ileum.
ontrols () and in syngeneic ( ) and allogeneic () transplanted m
3). Each symbol represents 1 animal, analyzed at the respective tim
xperiments. In immunohistochemistry slides, positive, AEC-stained
nd representative examples of immunohistochemistry in an untrea
right; lower panel). B, Expression of LFA-1 in ileum of all animals
ntreated BALB/c mouse (left) and an allogeneic transplanted anim
xpression of ICAM-1 on day 3 preceded inﬁltration of LFA-1 ce
igure 4. Expression of B7-1 and B7-2 in ileum. Expression of B7-1
), and allogeneic () transplanted mice. Expression was assessed a
animal, analyzed at the respective time points; bars represent med
f B7-1 in ileum. B, B7-1 expression in skin. In ileum and skin of a
hich could be observed neither in syngeneic mice nor in colon an
7-2 expression in skin of all animals. B7-2 expression in ileum wa
emained upregulated in the allogeneic group. In skin, B7-2 express
r syngeneic controls.
76ained increased in the ileum, skin, and liver but
ecreased in the colon on day 28 (data not shown).
4 Integrin interacts with VCAM-1 as a het-
sion of ICAM-1 and LFA-1 is shown in untreated and irradiated
pression was assessed as absent (0), weak (1), moderate (2), or strong
s; bars represent median values. Data were pooled from 2 separate
ppear in red. A, Expression of ICAM-1 in all animals (upper panel)
LB/c mouse (left) and an allogeneic transplanted animal on day 22
panel) and representative examples of immunohistochemistry in an
day 22 (right, lower panel). Of note, in allogeneic mice, increased
day 22.
-2 is shown in untreated and irradiated controls () and syngeneic
t (0), weak (1), moderate (2), or strong (3). Each symbol represents
ues. Data were pooled from 2 separate experiments. A, Expression
ic mice, there was a late upregulation of B7-1 on day 22 (P 	 .05),
of allogeneic transplant recipients. C, B7-2 expression in ileum. D,
cantly increased by irradiation in all treated animals (P 	 .05) and
reased in the allogeneic group from day 9 on, but not in irradiationExpres
ice. Ex
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Adhesion and Costimulatory Molecules in Murine GVHD
Brodimer in combination either with 1 integrin
41, VLA-4) or with 7 integrin (47). The latter
ombination also mediates the interaction of lympho-
ytes with MAdCAM-1 and ﬁbronectin [20]. To de-
ermine the relative contribution of 41
 and 47

ells to 4-integrin expression, we stained tissue sec-
ions from ileum, skin, and liver on day 9 and 22 with
monoclonal antibody against 7 integrin. In ileum
nd liver, 7
 cells with a lymphoid morphology in-
reased in parallel with 4 integrin expression, albeit
t lower levels, thus indicating that both 41
 and
47
 cells are involved in GVHD in these organs. In
ontrast, 7
 cells in the skin showed a different loca-
ion than 4
 cells (Figure 2C). Therefore, in skin, 7
ntegrin seems to be expressed either on macro-
hages or on E7
 lymphocytes, which are known
o interact with E-cadherin on dermal epithelial
ells [8].
xpression of ICAM-1, ICAM-2, and LFA-1
ICAM-1 was weakly expressed in the ileum and
olon, but not in the liver, of untreated mice on a
ariety of cell types in the lamina propria (endothelial
ells, ﬁbroblasts, macrophages, and lymphocytes). In
kin, ICAM-1 cells occurred only occasionally in the
urrounding of blood vessels. Irradiation and synge-
eic controls showed only a very mild and transient
ncrease of ICAM-1 expression on day 3 in ileum,
olon, and liver, whereas in skin, no alterations could
e observed (data not shown). In allogeneic trans-
lanted mice, however, ICAM-1 was upregulated in
he ileum on day 3 (P  .0293; Figure 3A), as well as
n the colon, liver, and skin on day 9 (P  .0293,
0043, and .0017, respectively), and remained in-
reased throughout the entire observation period. In
he skin of allogeneic mice, dermal endothelial cells
nd keratinocytes became ICAM-1 positive (data not
hown).
ICAM-2 was constitutively expressed in all organs
n macrophages and endothelium at weak to interme-
igure 5. Body weight and expansion of V3 T cells after transpl
yngeneic ( ) and allogeneic () transplantation (107 bone marrow
ice). Although in the syngeneic group mice recovered their pretran
esulted in a second loss of weight around day 24. B, Expansion o
ompartment is a hallmark of GVHD in allogeneic transplant recip
n the syngeneic transplanted group.iate levels, and its expression was not altered by (
B&MTrradiation. Only in the skin of the allogeneic group
as there a mild—but not signiﬁcant—increase in
CAM-2 expression on days 9, 22, and 28 (data not
hown).
The ligand for ICAM-1 and ICAM-2 on lympho-
ytes is LFA-1, the constitutive expression of which
ould be detected at weak to intermediate levels in all
rgans on lymphocytes and macrophages. Similar to
he results of 4 integrin, expression of LFA-l re-
ained constant or decreased because of irradiation-
nduced aplasia on day 3 and returned to pretransplan-
ation levels in syngeneic controls on day 9. In
llogeneic, but not in syngeneic transplanted mice,
here was a signiﬁcant increase in LFA-1 cells in skin
nd liver on day 9 (P  .005) and in ileum and colon
n day 22 (P  .002). The increase remained until the
nd of the observation period (Figure 3B). The in-
reased staining of 4 integrin and LFA-1 in the re-
pective tissues of the allogeneic group was closely
irrored by an increased expression of CD4 and
D8, with the exception of the liver, where staining of
D4 and CD8 was less intense than in the other 3
rgans (data not shown). Starting day 9 in the alloge-
eic group, there was a spreading of LFA-1 cells
rom the dermis to the epidermis in the skin and from
he veins to the parenchyma in the liver.
xpression of PECAM-1, E-Selectin,
nd MAdCAM-1
PECAM-1 was constitutively detectable in all tis-
ues at an intermediate degree of expression on endo-
helium and macrophages, the level of which was not
ltered by irradiation or syngeneic BMT. Only in the
olon of allogeneic transplanted animals there was a
ild, but not signiﬁcant, increase of expression on
ays 22 and 28 (data not shown).
E-selectin was not constitutively expressed in any
f the analyzed organs. Furthermore, we could not
bserve an early upregulation of E-selectin due to
rradiation or transplantation. At later time points
. A, Weight loss of animals after lethal irradiation and subsequent
8 spleen cells from female H-2d B10.D2 into female H-2d BALB/c
tion weight on day 10, induction of GVHD in the allogeneic group
T cells on days 9 and 22 within the CD4 (left) and CD8 (right)
xpansion of V3 T cells occurred only in the allogeneic, but notantation
plus 10
splanta
f V3
ients. Edays 9 and 22), E-selectin was upregulated to a cer-
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3ain degree in all organs; however, this effect could
artially also be observed in the syngeneic group (data
ot shown). Therefore, we could not ﬁnd clear evi-
ence for the involvement of E-selectin in the process
f GVHD in this model.
MAdCAM-1 was weakly expressed on high endo-
helial venules of Peyer patches, lamina propria, and
unica muscularis in the ileum and colon of untreated
ice. This pattern of expression remained unchanged
n irradiation and syngeneic controls, as well as in the
leum of the allogeneic group. Only in the colon of
llogeneic transplanted mice did a transient upregula-
ion of MAdCAM-1 occur, on day 9 (P  .0476); it
aned until day 28 (data not shown).
xpression of B7-1 and B7-2
In untreated controls, B7-1 was expressed on mac-
ophages in Peyer patches, lamina propria, and sub-
ucosa of the ileum and colon. In skin, B7-1 was only
poradically expressed in the dermis of controls and
yngeneic transplanted mice. B7-1 was not expressed
n the liver of controls or of syngeneic or allogeneic
ransplanted animals. On day 3, B7-1 expression in
leum became almost undetectable in all groups but
ecovered on day 9 (Figure 4A). Only in allogeneic
ransplanted mice did B7-1 expression in the ileum
ncrease above this pretransplantation level to an in-
ermediate expression on day 22 (P  .0148), whereas
n colon it was not affected by irradiation or BMT in
ny group. In skin, an upregulation of B7-1 was noted
n the dermis and epidermis on day 22 in allogeneic
ransplanted animals (P  .0222; Figure 4B).
B7-2 was weakly expressed on macrophages in
ll organs of untreated control mice. In contrast to
7-1, B7-2 expression was inducible by irradiation
n ileum (Figure 4C) and colon. On day 3, B7-2
xpression in the ileum and colon was increased in
igure 6. Expression of apoptotic markers in intestine and spleen
iven as 
OD, which is the optical density (OD) of the respective P
ame organ. A, Expression of Bax/Bcl-2 in ileum. B, Expression of Ba
emporarily increased in ileum and colon (data not shown) during G
ice, there was a striking dysbalance of these molecules in favor of
ransplanted mice during GVHD. Like Bax/Bcl-2, Fas/Fas-L expres
leum and spleen (data not shown). Expression of Fas/Fas-L was brradiation controls, as well as in syngeneic and a
78llogeneic transplanted animals. In the syngeneic
roup, B7-2 expression returned to normal levels on
ay 9 but remained increased in allogeneic trans-
lanted mice in intestinal organs. In skin and liver,
here was no effect of irradiation on B7-2 expres-
ion. In skin, there was a delayed upregulation of
7-2 from day 9 to 28 in the allogeneic group, but
ot in syngeneic controls (Figure 4D), whereas in
iver, no modulation in any group could be observed
hroughout the observation period.
xpression of Apoptotic Markers Bax, Bcl-2, Fas,
nd Fas-L
Expression of Bax and Bcl-2, as measured by RT-
CR, increased in the ileum of allogeneic transplanted
ice on days 3, 9, and 14 but returned to baseline
evels at later time points (Figure 6A). A similar pat-
ern was noted in colon (data not shown). In skin, no
lear change in the pattern of Bax/Bcl-2 expression
ould be observed, whereas in liver, the expression of
oth molecules was decreased after transplantation
data not shown). In general, the expression of Bax and
cl-2 was balanced in GVHD organs. In contrast,
here was a marked dysregulation of Bax and Bcl-2 in
pleen, with an upregulation of Bax and a simulta-
eous downregulation of Bcl-2 during the entire ob-
ervation period (Figure 6B).
Fas and Fas-L expression increased in ileum and
pleen of allogeneic transplanted mice on day 3 and
eturned to baseline levels thereafter. A similar pattern
as noted in colon (Figure 6C). In skin, no clear
hange in the pattern of Fas/Fas-L expression could
e observed, whereas in liver, the expression of both
olecules was decreased after transplantation (data
ot shown). Expression of Fas/Fas-L was balanced in
eneic transplanted mice. Results of semiquantitative RT-PCR are
oduct divided by the OD of an internal -actin standard from the
in spleen of untreated and allogeneic transplanted mice. Bax/Bcl-2
at similar levels. However, in the spleen of allogeneic transplanted
oapoptotic Bax. C, Expression of Fas/Fas-L in colon of allogeneic
mporarily increased during GVHD. A similar pattern was noted in
in all GVHD organs and in spleen.of allog
CR pr
x/Bcl-2
VHD
the pr
sion tell GVHD organs and in spleen.
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BISCUSSION
The H-2d identical mice strains B10.D2 and
ALB/c used in this study are known to differ in their
xpression of miHAgs [15] and endogenous proviruses
16]. In our model, GVHD induced by BMT and
otransplantation of 1  108 spleen cells became ev-
dent on day 22 by clinical symptoms, inﬁltration of
issues with donor lymphocytes, and subsequent de-
truction of tissue architecture. Without any treat-
ent, GVHD in this model is reported to be rapidly
ethal, with a median survival of 68 days and a mor-
ality of 90% on day 100 after transplantation [10].
e could show that between day 9 and 22, successful
mmune reconstitution of T, B, and NK lineages oc-
urred in syngeneic and allogeneic transplanted mice
hich were of donor type in the latter group. The
ramatic expansion of V3
 T cells is another hall-
ark of this GVHD model [21] and indicates initia-
ion of an allogeneic response to miHAgs of BALB/c
ecipient mice. miHAg-driven T-cell responses usu-
lly decline rapidly [22,23]. The fact that V3
 expan-
ion is still detectable on day 22 in our model can be
nterpreted as a delayed regression of the cytotoxic
-lymphocyte response or a redistribution of T cells
rom GVHD organs into the circulation. However,
he preferential expression of Bax in spleen on day 22
ndicates that activation-induced cell death is also op-
rational in our model.
Numerous studies have shown that adhesion mol-
cules are involved in the pathophysiology of GVHD
7,18,24-33]. The interaction between ICAM-1 and
FA-1 seems to be involved in the development of
utaneous [24-26], hepatic [18,27], and intestinal
28,29] GVHD. Also, VCAM-1 is upregulated in these 3
ajor GVHD target organs after transplantation
28,30,31], whereas PECAM-1 is reported to be up-
egulated in skin [25], but not in intestinal organs [29]
ffected by GVHD. Furthermore, E-selectin and
CAM-1, but not VCAM-1 or P-selectin, can be up-
egulated on vascular endothelium by the irradiation
sed in the conditioning regimen [32,33]. A recent
tudy could demonstrate that adhesion molecules play
n essential role in the initiation of an antihost cyto-
oxic T-lymphocyte response in intestinal GVHD [7].
owever, none of these studies has considered the
ynamics of CAM expression during GVHD. There-
ore, in this study, we provide the ﬁrst systematic
nalysis of CAMs and costimulatory molecules and
heir ligands in murine GVHD in a time- and organ-
esolved fashion.
As a direct consequence of lethal irradiation with
0 Gy, VCAM-1 was upregulated on day 3 in all
reated groups in the ileum and colon, and ICAM-1
as upregulated in the ileum of allogeneic mice. All
ther adhesion molecules, in particular E-selectin,
ere not affected by irradiation in the early phase after a
B&MTransplantation. However, it cannot be completely ex-
luded that some of these molecules might have been
pregulated very early but had already declined to
aseline expression by day 3 [33].
Whereas the number of B7-1 macrophages and
4 integrin–positive and LFA-1
 lymphocytes tempo-
arily decreased because of irradiation-induced apla-
ia, there was an early upregulation of B7-2 on day 3
n the ileum and colon of all irradiated animals. This
robably reﬂects the increased capacity of B7-2 to
ecome upregulated on macrophages and B cells in
esponse to lipopolysaccharide [34] or granulocyte-
acrophage colony-stimulating factor [35] compared
ith B7-1 and could be an indicator of intestinal
ucosal damage. Therefore, in our model, irradiation
aused early upregulation of VCAM-1, ICAM-1, and
7-2 only in intestinal organs, but not in skin or liver.
In syngeneic transplanted mice, these irradiation-
nduced phenomena waned by day 9 or 22. In contrast,
llogeneic transplanted animals showed sustained or
ven increased expression of these molecules during
urther follow-up. From day 9 on, VCAM-1 was up-
egulated in skin and liver, and ICAM-1 was upregu-
ated in skin, liver, and colon of allogeneic trans-
lanted mice. These 2 CAMs were shown to be the
ajor players in T-cell guidance, because they were
xpressed in virtually all GVHD organs of allogeneic
ecipients throughout the entire observation period.
ther CAMs, unexpectedly, seemed less important.
CAM-2 was only mildly upregulated in skin, and
ECAM-1 was upregulated only at later time points
n colon. It is interesting to note that the expression of
AdCAM-1 (which serves as a ligand for 47
 T
ells, which are essential for the induction of intestinal
VHD [19]) on intestinal high endothelial venules
as only temporarily increased in the colon around
ay 9. This suggests that other ligands for 47 inte-
rin like VCAM-1 [36] or the chemokine receptor
CR5 [7] must be equally important or even more
mportant for the homing of 47
 T cells to intesti-
al organs than MAdCAM-1 in our model. However,
e cannot exclude that MAdCAM might be more
mportant for GVHD induction in other strain com-
inations (eg, B10.BR ¡ CBA or B10.BR ¡
57BL/6 [19]). E-selectin was unspeciﬁcally upregu-
ated in allogeneic and syngeneic transplanted mice at
ater time points in all organs. This, together with the
nding that E-selectin/ knockout mice show only a
ild impairment in recruitment of leukocytes to sites
f inﬂammation [37], suggests that E-selectin plays no
mportant role in the development and maintenance
f GVHD.
Similar to the expression of CAMs, increased ex-
ression of the costimulatory molecule B7-2 after ir-
adiation in the intestinal organs disappeared in syn-
eneic transplanted animals on day 9. However, in the
llogeneic group, B7-2 remained increased in the il-
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3um and colon and became upregulated in the skin on
ay 22. B7-2 has been reported to be preferentially
xpressed over B7-1 on dermal dendritic cells, at least
n T cell–mediated skin disorders such as psoriasis
35]. Indeed, costimulation via B7-1 seemed to be less
mportant in our model, because B7-1 was virtually
naffected by irradiation and increased only in the
kin and ileum of allogeneic transplanted mice on day
2. The biologic signiﬁcance of these differences in
7-1 and B7-2 expression for GVHD remains to be
etermined. Blocking studies with monoclonal anti-
odies against B7-1 and B7-2 have shown that both
olecules are important for optimal CD4 and CD8
-cell expansion in murine GVHD. [12] Blockade of
he B7 family could signiﬁcantly reduce GVHD-asso-
iated lethality, but it did not result in complete ab-
ogation of the disorder [13].
Our results of an increased expression of apoptotic
arkers in GVHD target organs indicate that the
as/Fas-L pathway, as well as molecules such as Bax
nd Bcl-2, seem to be involved in the pathogenesis of
VHD [38]. This was recently conﬁrmed by gene
xpression proﬁling of skin affected by GVHD [39]. It
s interesting to note that we could not observe a gross
ysbalance in expression of proapoptotic and anti-
poptotic proteins in GVHD target organs, whereas
n spleen the pattern was skewed toward a preferential
xpression of Bax. This most likely reﬂects a dysregu-
ated Bax/Bcl-2 ratio in peripheral T cells; this has
een reported to occur in T cells early after transplan-
ation and results in an increased sensitivity of these
ells to apoptotic cell death [40]. However, because
ur RT-PCR data provide no information about
hich types of cells express these markers and whether
heir expression ﬁnally results in an increased rate of
poptotic tissue cells, further studies are needed to
eﬁne the role of apoptosis in GVHD.
An increase in 4 integrin–positive and LFA-1

ells was observed in the skin and liver of the alloge-
eic group on day 9 and in the ileum and colon on day
2. In ileum, colon, and liver, these 2 molecules were
lmost exclusively expressed on activated lymphocytes
nd on only a few macrophages in the lamina propria
f the ileum and colon. In contrast, in skin, a substan-
ial proportion of 4 integrin–positive and LFA-1

ells exhibited a dendritic morphology. Thus, at least
n skin, 4 integrin and LFA-1 seem to be expressed
ot only on activated T cells, but also on a number of
on–T cells during GVHD. Although the increase in
4 integrin and LFA-1 expression was paralleled by an
ncreased expression of CD4 and CD8 in GVHD
rgans and although the clinical onset of GVHD
ymptoms in allogeneic transplanted mice coincided
ith inﬁltration of 4 integrin–positive and LFA-1

ells, it is impossible to say whether this increased
xpression is the cause or the effect of GVHD induc-
ion. Several studies in mice and humans have shown
80hat by selective blockade of 4 integrin or LFA-1, the
nset or lethality of GVHD can be delayed [10] or
educed [11]. However, in all these trials, GVHD
ould not be completely abrogated, and in patients
fter BMT, the beneﬁcial effect of LFA-1 blockade on
VHD was thwarted by an increased rate of infec-
ious complications [41]. Therefore, increased expres-
ion of 4 integrin and LFA-1 on different cell types
ather seems to be secondary in GVHD, and inter-
ention at this stage will not result in prevention of the
isease.
To summarize our data in a downstream model of
vents, we found that after transplantation across mi-
Ag barriers, CAMs and adhesion molecules are ex-
ressed in a tissue-speciﬁc manner and exert different
unctions at different time points after transplantation.
e were able to distinguish between irradiation-in-
uced and alloreactivity-related effects. In the intes-
ine, irradiation induces upregulation of VCAM-1,
CAM-1, and B7-2. Because this early upregulation
oincides with the time slot of irradiation-induced
plasia, it does not result in signiﬁcant tissue T-cell
nvasion. However, expression of these molecules will
rovide an important costimulatory signal to either
aive (VCAM-1 and ICAM-1) or antigen-experienced
B7 family) donor T cells [42]. Interaction of
CAM-1 and ICAM-1 in intestinal organs with their
espective ligands on naive donor T cells, which have
een reported to be the predominant GVHD-induc-
ng population [43], could be one of the earliest events
n GVHD development. Therefore, our ﬁndings un-
erline the importance of gut mucosal damage caused
y the conditioning regimen in GVHD pathophysi-
logy [44], whereas in skin and liver, no such irradia-
ion-related effects could be observed.
Whereas in syngeneic transplanted mice, these
rradiation-induced alterations disappear between day
and 22, the presence of an alloresponse, indicated by
he systemic expansion of V3 T cells in the alloge-
eic group, results not only in the maintenance of
hese changes, but additionally in the initiation of a
hole cascade of proinﬂammatory signaling events.
pregulation of VCAM-1 and ICAM-1 occurs at the-
es stages in organs in which they have not been
reviously expressed, and, to a lesser extent, expres-
ion of ICAM-2 is increased in skin, as is that of
ECAM-1 and MAdCAM-1 in colon. This process
lso includes increased expression of costimulatory
olecules such as B7-1 and B7-2, as well as proapop-
otic and antiapoptotic molecules, and results in the
ecruitment of activated donor T cells into GVHD
arget organs. However, because many of these events
eem to be redundant or easily bypassed in case of
lockade, it is unlikely that interference with a partic-
lar pathway will result in signiﬁcant amelioration of
he disease at this stage of GVHD.In conclusion, early coblockade of VCAM-1 and
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BCAM-1 is an interesting strategy that has been shown
o result in a 70% reduction of active inﬂammation in
rohn disease [45]. To our knowledge, this approach
as not been tested in GVHD models. Alternatively,
he use of radioprotective substances such as keratin-
cyte growth factor [46] may help to diminish the
VHD-facilitating capacity of the conditioning regi-
en.
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